Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.4480
-0.0279 (-5.86%)
Nov 20, 2025, 9:41 AM EST - Market open
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $3.33 million as of November 20, 2025. Its market cap has decreased by -11.84% in one year.
Market Cap
3.33M
Enterprise Value
-580.56K
1-Year Change
-11.84%
Ranking
Category
Stock Price
$0.45
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $3.33M, a decrease of -94.89%. That is a compound annual growth rate of -50.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 3.54M | -11.20% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 939.79B |
| Johnson & Johnson | 487.91B |
| AbbVie | 411.64B |
| UnitedHealth Group | 279.99B |
| AstraZeneca | 275.69B |
| Novartis AG | 243.58B |
| Merck & Co. | 235.92B |
| Abbott Laboratories | 219.36B |